CIK 0001503802 · Non-accelerated filer<br>Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263931704
- Phone
- 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-29 | Poulton Stuart EVP, Chief Development Officer | Sale | −191 | $4.37 | $835 | 27,223 |
| 2025-07-22 | Abate Kristin Chief Accounting Officer | Sale | −238 | $4.00 | $952 | 9,475 |
| 2025-05-28 | Su Zhen Director | Grant or award · Nonstatutory Stock Option (right to buy) | +4,600 | 4,600 | ||
| 2025-05-28 | PAKIANATHAN DEEPIKA Director | Grant or award · Nonstatutory Stock Option (right to buy) | +4,600 | 4,600 | ||
| 2025-05-28 | Oliger Christy J. Director | Grant or award · Nonstatutory Stock Option (right to buy) | +4,600 | 4,600 | ||
| 2025-05-28 | Mirza Mansoor Raza Director | Grant or award · Nonstatutory Stock Option (right to buy) | +4,600 | 4,600 | ||
| 2025-05-28 | Greene Barry E Director | Grant or award · Nonstatutory Stock Option (right to buy) | +4,600 | 4,600 | ||
| 2025-05-28 | Schor Chen Director | Grant or award · Nonstatutory Stock Option (right to buy) | +4,600 | 4,600 | ||
| 2025-05-28 | BOHLIN GAREN G Director | Grant or award · Nonstatutory Stock Option (right to buy) | +4,600 | 4,600 | ||
| 2025-05-06 | Paulson Richard A. President and CEO | Sale | −236 | $7.12 | $2K | 82,503 |
| 2025-04-23 | Rangwala Reshma EVP & Chief Medical Officer | Sale | −419 | $6.17 | $3K | 28,853 |
| 2025-04-04 | Paulson Richard A. President and CEO | Sale | −245 | $3.74 | $916 | 82,739 |
| 2025-03-04 | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Sale | −3,445 | $6.29 | $22K | 34,314 |
| 2025-03-04 | Paulson Richard A. President and CEO | Sale | −11,694 | $6.29 | $74K | 82,984 |
| 2025-03-04 | Rangwala Reshma EVP & Chief Medical Officer | Sale | −3,587 | $6.29 | $23K | 29,272 |
| 2025-03-04 | Poulton Stuart EVP, Chief Development Officer | Sale | −3,548 | $6.29 | $22K | 27,414 |
| 2025-03-04 | Abate Kristin Chief Accounting Officer | Sale | −571 | $6.29 | $4K | 9,713 |
| 2025-03-04 | Mano Michael SVP, General Counsel&Secretary | Sale | −2,793 | $6.29 | $18K | 21,047 |
| 2025-02-28 | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Grant or award | +5,416 | 33,176 | ||
| 2025-02-28 | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Grant or award | +4,583 | 37,759 |
Page 4 of 7 · 138 trades